- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 298598, 8 pages
Antigenicity and Immunogenicity of Rotavirus VP6 Protein Expressed on the Surface of Lactococcus lactis
Laboratorio de Inmunología y Virología (LIV), Universidad Nacional de Quilmes, Bernal, B1876BXD Buenos Aires, Argentina
Received 29 April 2013; Revised 25 June 2013; Accepted 9 July 2013
Academic Editor: Jose R. Botella
Copyright © 2013 L. E. Esteban et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. G. Bermúdez-Humarán, P. Kharrat, J.-M. Chatel, and P. Langella, “Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines,” Microbial Cell Factories, vol. 10, supplement 1, p. S4, 2011.
- I. Mierau and M. Kleerebezem, “10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis,” Applied Microbiology and Biotechnology, vol. 68, no. 6, pp. 705–717, 2005.
- Y. Le Loir, V. Azevedo, S. C. Oliveira et al., “Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production,” Microbial Cell Factories, vol. 4, no. 1, article 2, 2005.
- S. Nouaille, L. A. Ribeiro, A. Miyoshi et al., “Heterologous protein production and delivery systems for Lactococcus lactis,” Genetics and Molecular Research, vol. 2, no. 1, pp. 102–111, 2003.
- B. Jiang, M. Patel, and U. Parashar, “Rotavirus vaccines for global use: what are the remaining issues and challenges?” Human Vaccines, vol. 6, no. 5, pp. 425–427, 2010.
- U. D. Parashar, J. P. Alexander, and R. I. Glass, “Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP),” MMWR. Recommendations and Reports, vol. 55, no. RR-12, pp. 1–13, 2006.
- R. L. Ward, M. M. McNeal, and A. D. Steele, “Why does the world need another rotavirus vaccine?” Therapeutics and Clinical Risk Management, vol. 4, no. 1, pp. 49–63, 2008.
- C. A. Perez, C. Eichwald, O. Burrone, and D. de Mendoza, “Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice,” Journal of Applied Microbiology, vol. 99, no. 5, pp. 1158–1164, 2005.
- B. Marelli, A. R. Perez, C. Banchio, D. de Mendoza, and C. Magni, “Oral immunization with live Lactococcus lactis expressing rotavirus VP8* subunit induces specific immune response in mice,” Journal of Virological Methods, vol. 175, no. 1, pp. 28–37, 2011.
- J. Rodríguez-Díaz, R. Montava, R. Viana, J. Buesa, G. Pérez-Martínez, and V. Monedero, “Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein,” Biotechnology Letters, vol. 33, no. 6, pp. 1169–1175, 2011.
- Y.-J. Li, G.-P. Ma, G.-W. Li et al., “Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 708460, 9 pages, 2010.
- V. Enouf, P. Langella, J. Commissaire, J. Cohen, and G. Corthier, “Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic,” Applied and Environmental Microbiology, vol. 67, no. 4, pp. 1423–1428, 2001.
- M. K. Estes and A. Z. Kapikian, “Rotviruses,” in Fields Virology, B. N. Fields, D. M. Knipe, and P. M. Howley, Eds., Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2007.
- B. Tang, J. M. Gilbert, S. M. Matsui, and H. B. Greenberg, “Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis,” Virology, vol. 237, no. 1, pp. 89–96, 1997.
- A. H. Choi, M. M. McNeal, M. Basu et al., “Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses,” Vaccine, vol. 20, no. 27-28, pp. 3310–3321, 2002.
- T. Maniatis, E. F. Fritsch, and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, 1982.
- J. Gray and U. Desselberger, Rotaviruses Methods and Protocols, Humana Press, Totowa, NJ, USA, 2000.
- R. Boom, C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheim-van Dillen, and J. van der Noordaa, “Rapid and simple method for purification of nucleic acids,” Journal of Clinical Microbiology, vol. 28, no. 3, pp. 495–503, 1990.
- Y. Dieye, S. Usai, F. Clier, A. Gruss, and J.-C. Piard, “Design of a protein-targeting system for lactic acid bacteria,” Journal of Bacteriology, vol. 183, no. 14, pp. 4157–4166, 2001.
- M. A. Reuter, S. Hanniffy, and J. M. Wells, “Expression and delivery of heterologous antigens using lactic acid bacteria,” in Methods in Molecular Medicine: Vaccine Protocols, A. Robinson, M. J. Hudson, and M. P. Cranage, Eds., Humana Press Inc., Totowa, NJ, USA, 2003.
- G. A. Villegas, M. H. Argüelles, A. A. Castello, N. J. Mas, and G. Glikmann, “A rapid method to produce high yields of purified rotavirus particles,” Journal of Virological Methods, vol. 104, no. 1, pp. 9–19, 2002.
- P. M. Norton, H. W. G. Brown, J. M. Wells, A. M. Macpherson, P. W. Wilson, and R. W. F. Le Page, “Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis,” FEMS Immunology and Medical Microbiology, vol. 14, no. 2-3, pp. 167–177, 1996.
- K. K. Yam, F. Hugentobler, P. Pouliot et al., “Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB/c mice,” Journal of Medical Microbiology, vol. 60, no. 9, pp. 1248–1260, 2011.
- K. Robinson, L. M. Chamberlain, M. C. Lopez et al., “Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C,” Infection and Immunity, vol. 72, no. 5, pp. 2753–2761, 2004.
- K. Robinson, L. M. Chamberlain, K. M. Schofield, J. M. Wells, and R. W. F. Le Page, “Oral vaccination of mice against tetanus with recombinant Lactococcus lactis,” Nature Biotechnology, vol. 15, no. 7, pp. 653–657, 1997.
- J. M. Wells, P. W. Wilson, P. M. Norton, M. J. Gasson, and R. W. F. Le Page, “Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge,” Molecular Microbiology, vol. 8, no. 6, pp. 1155–1162, 1993.
- J. W. Burns, M. Siadat-Pajouh, A. A. Krishnaney, and H. B. Greenberg, “Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity,” Science, vol. 272, no. 5258, pp. 104–107, 1996.
- B. Corthésy, Y. Benureau, C. Perrier et al., “Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion,” Journal of Virology, vol. 80, no. 21, pp. 10692–10699, 2006.
- S. C. Chen, E. F. Fynan, H. L. Robinson et al., “Protective immunity induced by rotavirus DNA vaccines,” Vaccine, vol. 15, no. 8, pp. 899–902, 1997.
- J. E. Herrmann, S. C. Chen, E. F. Fynan et al., “Protection against rotavirus infections by DNA vaccination,” Journal of Infectious Diseases, vol. 174, supplement 1, pp. S93–S97, 1996.
- A. H.-C. Choi, K. Smiley, M. Basu et al., “Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection,” Vaccine, vol. 25, no. 16, pp. 3215–3218, 2007.
- A. H.-C. Choi, M. Basu, M. M. McNeal, J. D. Clements, and R. L. Ward, “Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein,” Journal of Virology, vol. 73, no. 9, pp. 7574–7581, 1999.
- M. M. McNeal, M. Basu, J. A. Bean et al., “Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge,” Vaccine, vol. 25, no. 33, pp. 6224–6231, 2007.
- J. W. Burns, A. A. Krishnaney, P. T. Vo, R. V. Rouse, L. J. Anderson, and H. B. Greenberg, “Analyses of homologous rotavirus infection in the mouse model,” Virology, vol. 207, no. 1, pp. 143–153, 1995.
- A. S. Laimbacher, L. E. Esteban, A. A. Castello, et al., “HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice,” Molecular Therapy, vol. 20, no. 9, pp. 1810–1820, 2012.
- R. Ward, “Mechanisms of protection against rotavirus infection and disease,” Pediatric Infectious Disease Journal, vol. 28, no. 3, supplement, pp. S57–S59, 2009.
- I. Mierau, P. Leij, I. van Swam et al., “Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin,” Microbial Cell Factories, vol. 4, article 15, 2005.